Chiome Bioscience Inc. | Income Statement
Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
324,127.00
370,344.40
280,113.00
252,215.00
259,895.00
212,851
Cost of Goods Sold (COGS) incl. D&A
122,327.00
107,677.10
224,783.00
227,638.00
93,532.00
107,257
Gross Income
201,800.00
262,667.30
55,330.00
24,577.00
166,363.00
105,594
SG&A Expense
614,960.00
-
1,325,246.00
1,066,934.00
1,054,231.00
1,644,715
EBIT
413,160.00
1,154,107.80
1,269,916.00
1,042,357.00
887,868.00
1,539,121
Unusual Expense
-
-
23,814.00
454,121.00
3,181.00
2,869
Non Operating Income/Expense
9,660.00
27,319.90
6,087.00
6,622.00
4,679.00
5,125
Interest Expense
2,472.00
96.00
65.00
483.00
185.00
-
Pretax Income
424,813.00
1,179,973.10
1,280,695.00
1,501,280.00
880,150.00
1,531,082
Income Tax
2,077.00
422.70
2,019.00
10,117.00
2,420.00
2,420
Consolidated Net Income
426,890.00
1,180,395.70
1,282,714.00
1,491,162.00
882,570.00
1,533,502
Net Income
426,890.00
1,150,298.50
1,282,714.00
1,491,162.00
882,570.00
1,533,502
Net Income After Extraordinaries
426,890.00
1,150,298.50
1,282,714.00
1,491,162.00
882,570.00
1,533,502
Net Income Available to Common
426,890.00
1,150,298.50
1,282,714.00
1,491,162.00
882,570.00
1,533,502
EPS (Basic)
25.48
56.44
58.29
65.91
33.48
57.26
Basic Shares Outstanding
16,750.90
20,381.10
22,004.00
22,625.20
26,358.20
26,781.40
EPS (Diluted)
25.48
56.44
58.29
65.91
33.48
57.26
Diluted Shares Outstanding
16,750.90
20,381.10
22,004.00
22,625.20
26,358.20
26,781.40
EBITDA
357,705.00
1,046,430.70
1,167,548.00
929,255.00
877,275.00
1,532,105
Other Operating Expense
-
107,677.10
-
-
-
-
Non-Operating Interest Income
479.00
1,550.70
7,013.00
2,306.00
41.00
42
Minority Interest Expense
-
30,097.30
-
-
-
-
About Chiome Bioscience
View Profile
